CytoCy5S™, a compound of many structures. in vitro and in vivo evaluation of four near-infrared fluorescent substrates of nitroreductase (NTR)
Source abstract
Abstract
CytoCy5S™, a quenched, red-shifted fluorescent probe , has been used to exploit the imaging potential of the nitroreductase (NTR) reporter gene platform. Its use has been reported in a number of publications, however there are discrepancies in both the reported structure and its physicochemical properties. Herein, we aim to highlight these discrepancies and to define the best candidate of the four substrates under study for preclinical work in NTR reporting by optical applications. We report the synthesis, purification and characterisation of four NTR substrates, including alternately described structures currently referred by the name CytoCy5S. A comparative NTR enzymatic assay was performed to assess the spectroscopic characteristics of the different reductively activated probes. The NTR expressing triple-negative breast carcinoma cell line, MDA-MB-231 NTR + , was employed to compare, both in vitro and in vivo , the suitability of these fluorescent probes as reporters of NTR activity. Comparison of the reporting properties was achieved by flow cytometry , fluorescence microscopy and optical imaging , both in vivo and ex vivo . This study evaluated the different spectroscopic and biological characteristics of the four substrates and concluded that substrate 1 presents the best features for oncological in vivo preclinical optical imaging .
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced Fluorescence Microscopy Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Optical imaging probes in oncology10.18632/oncotarget.9066 ↗
2. Multimodality reporter gene imaging: construction strategies and application10.7150/thno.24108 ↗
3. Reporter gene imaging and its role in imaging-based drug development10.1016/j.drudis.2019.12.010 ↗
4. A review of NIR dyes in cancer targeting and imaging10.1016/j.biomaterials.2011.06.024 ↗
5. NIR fluorescent small molecules for intraoperative imaging10.1002/wnan.1337 ↗
6. Optical properties of biological tissues: a review10.1088/0031-9155/58/11/R37 ↗
7. Tissue-specific near-infrared fluorescence imaging10.1021/acs.accounts.6b00239 ↗
8. Nitroreductase, a near-infrared reporter platform for in vivo time-domain optical imaging of metastatic cancer10.1158/0008-5472.CAN-12-2649 ↗
9. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results10.1038/nm.2472 ↗
10. Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP10.1007/s11307-013-0637-8 ↗
11. A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer10.1158/1078-0432.CCR-15-2640 ↗
12. CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model10.1016/j.ebiom.2020.102783 ↗
13. In vivo albumin traps photosensitizer monomers from self-assembled phthalocyanine nanovesicles: a facile and switchable theranostic approach10.1021/jacs.8b12167 ↗
14. Cytotoxicity, fluorescence tagging and gene-expression study of CuInS/ZnS QDS - meso (hydroxyphenyl) porphyrin conjugate against human monocytic leukemia cells10.1038/s41598-020-61881-8 ↗
15. Carbazole-linked near-infrared aza-BODIPY dyes as triplet sensitizers and photoacoustic contrast agents for deep-tissue imaging10.1002/chem.201605702 ↗
16. Near-infrared-II molecular dyes for cancer imaging and surgery10.1002/adma.201900321 ↗
17. The structure and 13C-NMR of an indolenium squaraine dye10.1016/S0143-7208(99)00043-1 ↗
18. D-PET-controlled “off-on” polarity-sensitive probes for reporting local hydrophilicity within lysosomes10.1038/srep35627 ↗
19. Near-infrared fluorescent probes for imaging of intracellular Mg2+ and application to multi-color imaging of Mg2+, ATP, and mitochondrial membrane potential10.1021/acs.analchem.9b03872 ↗
20. Near-infrared pH-activatable fluorescent probes for imaging primary and metastatic breast tumors10.1021/bc100584d ↗
21. Activatable fluorescent probes: a new concept in optical molecular imaging10.2174/092986712803341511 ↗
22. An activatable NIR fluorescent rosol for selectively imaging nitroreductase activity10.1016/j.snb.2019.127446 ↗
23. A novel off-on fluorescent probe for imaging of hypoxia in tumor cell10.1016/j.jphotochem.2017.11.015 ↗
24. In vivo bacterial imaging without engineering; A novel probe-based strategy facilitated by endogenous nitroreductase enzymes10.2174/1566523215666150126122712 ↗
25. Fluorescent imaging of bacterial infections and recent advances made with multimodal radiopharmaceuticals10.1007/s40336-019-00322-7 ↗
26. An elegant nitroreductase responsive fluorescent probe for selective detection of pathogenic Listeria in vitro and in vivo10.1016/j.talanta.2019.02.026 ↗
27. A novel off–on fluorescent probe for sensitive imaging of mitochondria-specific nitroreductase activity in living tumor cells10.1039/C7OB00781G ↗
28. Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB195410.1038/sj.cgt.7700171 ↗
29. A new in vitro model for stem cell differentiation and interaction10.1016/j.scr.2008.10.002 ↗
30. CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy10.1158/1535-7163.MCT-08-0707 ↗
31. Crystal structure of FMN-dependent nitroreductase from Escherichia coli B: A prodrug-activating enzyme10.1021/jm000159m ↗
32. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form10.1021/jm030843b ↗
33. Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals10.1038/gt.2011.101 ↗
34. Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice10.7150/thno.8077 ↗
35. Ultrasound-guided delivery of thymidine kinase–nitroreductase dual therapeutic genes by PEGylated-PLGA/PEI nanoparticles for enhanced triple negative breast cancer therapy10.2217/nnm-2017-0328 ↗
36. Microvesicle-mediated delivery of minicircle DNA results in effective gene-directed enzyme prodrug cancer therapy10.1158/1535-7163.MCT-19-0299 ↗
37. West
38. Thomas
39. Bhaumik
40. Cytiva · 2020
41. Chapter 8 advances in biological screening for lead discovery10.1039/9781847559890-00243 ↗
42. Inglese · Measuring Biological Responses with Automated Microscopy · 2006 · 414
43. Bioreductive fluorescent imaging agents: applications to tumour hypoxia10.1039/C6CC01037G ↗
44. Mitochondrial nitroreductase activity enables selective imaging and therapeutic targeting10.1021/jacs.6b06229 ↗
45. Charge-shift probes of membrane-potential - characterization of aminostyrylpyridinium dyes on the squid giant-axon10.1016/S0006-3495(85)83878-9 ↗
46. Near-instant surface-selective fluorogenic protein quantification using sulfonated triarylmethane dyes and fluorogen activating proteins10.1039/C4OB02309A ↗